Theravance Biopharma Inc Capital Reinvestment Ratio

Latest as of March 2018: 0.06x

Theravance Biopharma Inc capital reinvestment ratio. Theravance Biopharma Inc (0TB) has a Capital Reinvestment Ratio of 0.06x as of March 2018, meaning it reinvests 0% of its operating cash flow (€49.83 Million) in capital expenditures (€2.77 Million). See cash generation quality of Theravance Biopharma Inc to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.06x

Capex / Operating Cash Flow

Operating Cash Flow

€49.83 Million

EUR

Capital Expenditures

€2.77 Million

EUR

Data as of

Mar 2018

Most recent filing

Theravance Biopharma Inc Capital Reinvestment Ratio by Year (None–None)

Theravance Biopharma Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see Theravance Biopharma Inc cash conversion from operations.

Year	Reinvestment Ratio	Operating CF (EUR)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow